Dr. Deborah Rotenstein, M.D

NPI: 1588669030
Total Payments
$100,063
2023 Payments
$22.46
Companies
15
Transactions
225

Payment Breakdown by Category

Other$61,253 (61.2%)
Consulting$27,210 (27.2%)
Travel$7,204 (7.2%)
Food & Beverage$4,071 (4.1%)
Education$324.86 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $38,248 25 38.2%
Consulting Fee $27,210 8 27.2%
Honoraria $23,005 4 23.0%
Travel and Lodging $7,204 20 7.2%
Food and Beverage $4,071 157 4.1%
Education $324.86 11 0.3%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $23,872 58 $0 (2023)
Ultragenyx Pharmaceutical Inc. $22,554 33 $0 (2022)
TOLMAR Pharmaceuticals, Inc. $22,140 3 $0 (2022)
Ipsen Biopharmaceuticals, Inc $18,435 8 $0 (2019)
AbbVie Inc. $6,988 32 $0 (2021)
Ferring Pharmaceuticals Inc. $3,280 13 $0 (2020)
PFIZER INC. $1,720 17 $0 (2020)
Lilly USA, LLC $310.00 28 $0 (2020)
Genentech USA, Inc. $279.72 6 $0 (2018)
Shire North American Group Inc $173.98 2 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $22.46 1 Novo Nordisk Inc ($22.46)
2022 $885.00 2 TOLMAR Pharmaceuticals, Inc. ($535.00)
2021 $28,132 21 TOLMAR Pharmaceuticals, Inc. ($20,000)
2020 $6,488 12 Ultragenyx Pharmaceutical Inc. ($4,775)
2019 $37,383 59 Ipsen Biopharmaceuticals, Inc ($17,432)
2018 $6,831 64 Novo Nordisk Inc ($6,124)
2017 $20,320 66 Novo Nordisk Inc ($14,247)

All Payment Transactions

225 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
01/18/2023 Novo Nordisk Inc Norditropin (Biological) Food and Beverage In-kind items and services $22.46 General
Category: Growth Hormone
04/07/2022 TOLMAR Pharmaceuticals, Inc. FENSOLVI (Drug) Consulting Fee Cash or cash equivalent $535.00 General
Category: Central Precocious Puberty (CPP)
04/06/2022 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Consulting Fee In-kind items and services $350.00 General
Category: XLH Metabolic Bone Disorder
12/22/2021 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,100.00 General
Category: XLH Metabolic Bone Disorder
12/15/2021 AbbVie Inc. LUPRON DEPOT (Drug) Food and Beverage In-kind items and services $20.97 General
Category: ENDOCRINOLOGY
12/14/2021 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Travel and Lodging Cash or cash equivalent $603.00 General
Category: XLH Metabolic Bone Disorder
12/14/2021 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Food and Beverage Cash or cash equivalent $108.22 General
Category: XLH Metabolic Bone Disorder
11/30/2021 Novo Nordisk Inc Norditropin (Biological) Food and Beverage In-kind items and services $14.64 General
Category: Growth Hormone
11/22/2021 AbbVie Inc. LUPRON DEPOT (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,250.00 General
Category: ENDOCRINOLOGY
11/18/2021 Novo Nordisk Inc Norditropin (Biological) Food and Beverage In-kind items and services $22.53 General
Category: Growth Hormone
11/17/2021 AbbVie Inc. LUPRON DEPOT (Drug) Food and Beverage In-kind items and services $113.58 General
Category: ENDOCRINOLOGY
11/11/2021 TOLMAR Pharmaceuticals, Inc. FENSOLVI (Drug) Honoraria Cash or cash equivalent $20,000.00 General
Category: Central Precocious Puberty (CPP)
11/04/2021 Novo Nordisk Inc Norditropin (Biological) Food and Beverage In-kind items and services $16.01 General
Category: Growth Hormone
10/26/2021 AbbVie Inc. LUPRON DEPOT (Drug) Food and Beverage In-kind items and services $23.69 General
Category: ENDOCRINOLOGY
10/19/2021 BioMarin Pharmaceutical Inc. Food and Beverage In-kind items and services $25.50 General
10/12/2021 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Food and Beverage In-kind items and services $19.25 General
Category: XLH Metabolic Bone Disorder
10/12/2021 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Food and Beverage In-kind items and services $1.36 General
Category: XLH Metabolic Bone Disorder
09/15/2021 BioMarin Pharmaceutical Inc. Food and Beverage In-kind items and services $20.84 General
09/15/2021 BioMarin Pharmaceutical Inc. Food and Beverage In-kind items and services $18.70 General
06/30/2021 Novo Nordisk Inc Norditropin (Biological) Food and Beverage In-kind items and services $18.90 General
Category: Growth Hormone
06/09/2021 AbbVie Inc. SYNTHROID (Drug) Food and Beverage In-kind items and services $4.72 General
Category: IMMUNOLOGY
04/07/2021 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Honoraria Cash or cash equivalent $700.00 General
Category: XLH Metabolic Bone Disorder
03/22/2021 AbbVie Inc. LUPRON DEPOT (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,350.00 General
Category: ENDOCRINOLOGY
03/17/2021 Ultragenyx Pharmaceutical Inc. Crysvita (Drug) Honoraria Cash or cash equivalent $700.00 General
Category: XLH Metabolic Bone Disorder
12/23/2020 TOLMAR Pharmaceuticals, Inc. FENSOLVI (Drug) Honoraria Cash or cash equivalent $1,605.00 General
Category: Central Precocious Puberty (CPP)

About Dr. Deborah Rotenstein, M.D

Dr. Deborah Rotenstein, M.D is a Pediatric Endocrinology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588669030.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deborah Rotenstein, M.D has received a total of $100,063 in payments from pharmaceutical and medical device companies, with $22.46 received in 2023. These payments were reported across 225 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($38,248).

Practice Information

  • Specialty Pediatric Endocrinology
  • Location Pittsburgh, PA
  • Active Since 06/20/2005
  • Last Updated 10/02/2020
  • Taxonomy Code 2080P0205X
  • Entity Type Individual
  • NPI Number 1588669030

Products in Payments

  • FENSOLVI (Drug) $22,140
  • Norditropin (Drug) $21,835
  • INCRELEX (Drug) $17,432
  • CRYSVITA (Drug) $10,373
  • Cryvista (Drug) $4,775
  • Crysvita (Drug) $4,582
  • LUPRON DEPOT (Drug) $3,772
  • ZOMACTON (Drug) $3,280
  • Lupron (Drug) $2,984
  • GENOTROPIN (Drug) $1,720
  • Tresiba (Drug) $1,500
  • Somatuline Depot 120mg-.5ml (Drug) $975.00
  • Xolair (Biological) $245.78
  • HUMALOG (Drug) $203.93
  • CUVITRU (Biological) $173.98
  • Synthroid (Drug) $144.13
  • Triptodur (Drug) $120.13
  • Norditropin (Biological) $113.92
  • Lupron Depot (Drug) $61.45
  • NovoLog (Drug) $53.60

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Endocrinology Doctors in Pittsburgh